94300 ⎘
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring Aralkyl radicals
Sub-classes:TETRAHYDROISOQUINOLINYLMETHYLBENZAMIDE COMPOUNDS
#2METHOD FOR SYNTHESIZING NUCIFERINE OR DERIVATIVE THEREOF, DERIVATIVE OF NUCIFERINE AND USE THEREOF
#3AMIDE COMPOUND AS POTASSIUM CHANNEL REGULATOR, AND PREPARATION THEREFOR AND USE THEREOF
#4AROMATIC RING-FUSED HETEROCYCLIC RING COMPOUND AS POTASSIUM CHANNEL REGULATOR, AND PREPARATION THEREFOR AND USE THEREOF
#5Arylamine Compound and Use thereof, Electroluminescent Device and Display Apparatus
#6SMALL MOLECULE MODULATORS OF FERROPTOSIS
#7USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VIII
#8Bicyclic compounds
#9CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS
#10Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
#11Amido compounds as AhR modulators
#12Benzylisoquinoline Alkaloid (BIA) Precursor Producing Microbes, and Methods of Making and Using the Same
#13Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors
#143′ end caps for RNAi agents for use in RNA interference
#15Compounds useful for treating a or infection
#16Sphinogosine-1 -phosphate receptor modulators for treatment of cardiopulmonary disorders
#17Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof
#18Condensed cyclic compound and organic light-emitting device including the same
#19Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates
#20Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#21Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same
#22Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same
#23Sphinogosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders
#243′end caps for RNAi agents for use in RNA interference
#25Phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors
#26Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof
#27Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds
#28COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#29NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, LIGHTING SYSTEM, AND IMAGE FORMING APPARATUS HAVING THE COMPOUND
#30Cyclic amide BACE-1 inhibitors having a benzamide substituent
#31Palladium catalyst, method for its preparation and its use
#32Nitrogen-containing condensed heterocyclic compound
#33Palladium catalyst, method for its preparation and its use
#34Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
#35Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
#36ISOQUINOLINE DERIVATIVE
#37Cyclic amine BACE-1 inhibitors having a benzamide substituent
#38Isoquinoline derivative
#39Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
#40SUBSTITUTED 1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES
#41Cyclic amine BACE-1 inhibitors having a benzamide substituent
#42Trisubstituted 3,4-dihydro-1H-isoquinolin compound, process for its preparation, and its use
#43Fungal cell wall synthesis gene
#44Tetrahydroisoquinoline derivatives
#45Fungal cell wall synthesis gene
#46FUNGAL CELL WALL SYNTHESIS GENE
#47METHOD FOR TREATING ADAMTS-5-ASSOCIATED DISEASE
#48Intermediates useful for making tetrabenazine compounds
#49Method for making tetrabenazine compounds
#50Fungal cell wall synthesis gene
#51Fungal cell wall synthesis gene
#52Methods of Treatment of Amyloidosis Using Subsituted Ethanolcyclicamine Aspartyl Protease Inhibitors
#53Substituted 4-phenyltetrahydroisoquinolines, pharmaceutical compositions comprising them and therapeutic methods for their use
#54Substituted Tetrahydroisoquinoline Compounds for Cancer Therapy
#55Substituted tetrahydroisoquinoline compounds, methods of making, and their use
#56Amides as BACE inhibitors
#57Biaryl sulfonamides and methods for using same
#58Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
#59Fungal cell wall synthesis gene
#60Fungal cell wall synthesis gene
#61Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
#62Novel enantiomers of etrahydroisoquinoline derivatives and theirpharmaceutically acceptable salts, their preparations and pharmaceutical compositions
#63Arylalkylcarbamate derivatives and production thereof
#64Method for treating ADAMTS-5-associated disease
#65Biaryl sulfonamides and methods for using same
#66Cyclic amine BACE-1 inhibitors having a benzamide substituent
#67β-Adrenoreceptor agonists, agonist compositions and methods of using
#68Heterocyclic amide compounds as apolipoprotein b inhibitors
#69Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
#70Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
#71Compounds and methods for modulation of estrogen receptors